Breast Neoplasms: all 12,820 studies

Page 47 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast CancerCompletedNCT00429299Phase 2Results posted
• Purged Circulating Tumor Cells (CTCs) From Metastatic Breast CancerCompletedNCT00429182Phase 2Results posted
• Herceptin and GM-CSF for Metastatic Breast CancerCompletedNCT00429104Phase 2Results posted
• Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) PatientsCompletedNCT00428922Phase 2Results posted
• A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.CompletedNCT00428220Not applicableResults posted
• Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast CancerCompletedNCT00426556Phase 1Results posted
• An Open Label Phase II Trial of BIBW 2992 in Patients With HER2-negative Metastatic Breast CancerCompletedNCT00425854Phase 2Results posted
• ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous TreatmentCompletedNCT00425672Phase 1/2Results posted
• Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00423917Phase 2Results posted
• Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast CancerCompletedNCT00422903Phase 2Results posted
• Regional Anesthesia and Breast Cancer RecurrenceCompletedNCT00418457Phase 3Results posted
• Standard Versus Continuous Capecitabine in Advanced Breast CancerCompletedNCT00418028Phase 2/3Results posted
• A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast CancerTerminatedNCT00417885Phase 1/2Results posted
• Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast CancerCompletedNCT00416715Phase 2Results posted
• Educational Program in Younger Women Who Have Recently Finished Treatment for Stage I or Stage II Breast CancerCompletedNCT00416572Not applicableResults posted
• A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast CancerCompletedNCT00411788Phase 2Results posted
• S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the BoneCompletedNCT00410813Phase 2Results posted
• Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantCompletedNCT00408681Not applicableResults posted
• Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By SurgeryStatus unknownNCT00408408Phase 3Results posted
• Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With SurgeryCompletedNCT00407888Phase 2Results posted
• Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast CancerCompletedNCT00405938Phase 2Results posted
• Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast CancerCompletedNCT00404066Phase 2Results posted
• Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast CancerCompletedNCT00403130Phase 2Results posted
• A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)CompletedNCT00399802Phase 2Results posted
• Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast CancerCompletedNCT00399529Phase 2Results posted
• A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast CancerCompletedNCT00398567Phase 1/2Results posted
• Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast CancerCompletedNCT00394251Phase 2Results posted
• ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast CancerCompletedNCT00394082Phase 2Results posted
• Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast CancerCompletedNCT00393939Phase 3Results posted
• Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast CancerCompletedNCT00392392Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.CompletedNCT00391092Phase 3Results posted
• Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-PositiveCompletedNCT00390455Phase 3Results posted
• E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00388726Phase 3Results posted
• Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk StatusCompletedNCT00383500Not applicableResults posted
• Psychosocial Outcomes in Online Cancer Support GroupsCompletedNCT00382785Not applicableResults posted
• Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast CancerActive, not recruitingNCT00382070Phase 3Results posted
• S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With ChemoCompletedNCT00382018Phase 3Results posted
• Phase II of Naltrexone in Hormone-Refractory Metastatic Breast CancerTerminatedNCT00379197Phase 2Results posted
• Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesCompletedNCT00377156Phase 3Results posted
• Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast CancerTerminatedNCT00376805Phase 2Results posted
• Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00376688Phase 2Results posted
• Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node DissectionCompletedNCT00376597Results posted
• Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast CancerTerminatedNCT00375752Phase 4Results posted
• The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone LossCompletedNCT00375505Phase 3Results posted
• Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone LesionsCompletedNCT00375427Phase 3Results posted
• Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast CancerCompletedNCT00374322Phase 3Results posted
• A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast CancerCompletedNCT00373256Phase 3Results posted
• A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And CapecitabineTerminatedNCT00373113Phase 3Results posted
• Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast CancerTerminatedNCT00372996Phase 2Results posted
• Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 PositiveCompletedNCT00372424Phase 1Results posted
• Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast CancerCompletedNCT00371345Phase 2Results posted
• A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast CancerCompletedNCT00371254Phase 2Results posted
• A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast CancerCompletedNCT00370552Phase 2Results posted
• VEGF Trap in Treating Patients With Metastatic Breast CancerCompletedNCT00369655Phase 2Results posted
• Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast CancerCompletedNCT00368875Phase 1/2Results posted
• Phase II Trial of SAHA & Tamoxifen for Patients With Breast CancerCompletedNCT00365599Phase 2Results posted
• Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast CancerCompletedNCT00365417Phase 2Results posted
• Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast CancerCompletedNCT00365365Phase 2Results posted
• Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast CancerCompletedNCT00365105Phase 3Results posted
• Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast CancerCompletedNCT00364611Phase 2Results posted
• Iressa Follow-up TrialCompletedNCT00357734Phase 3Results posted
• Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast CancerCompletedNCT00357110Phase 2Results posted
• Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast CancerCompletedNCT00356811Phase 2Results posted
• The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients.CompletedNCT00356148Phase 4Results posted
• Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast CancerCompletedNCT00354640Phase 2Results posted
• Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast CancerCompletedNCT00347919Phase 2Results posted
• Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast CancerTerminatedNCT00347438Phase 2Results posted
• Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast CancerCompletedNCT00343863Not applicableResults posted
• Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast CancerTerminatedNCT00343512Phase 2Results posted
• Pilocarpine in Treating Vaginal Dryness in Patients With Breast CancerCompletedNCT00343382Phase 3Results posted
• Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast CancerCompletedNCT00338728Phase 2Results posted
• A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard ChemotherapyCompletedNCT00338286Phase 3Results posted
• E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and TaxanesCompletedNCT00337103Phase 3Results posted
• Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast CancerCompletedNCT00334802Phase 2Results posted
• Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast CancerCompletedNCT00334542Phase 2Results posted
• A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast CancerCompletedNCT00333775Phase 3Results posted
• A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone LossTerminatedNCT00333229Phase 4Results posted
• Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast CancerCompletedNCT00332709Phase 3Results posted
• Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00331630Early Phase 1Results posted
• Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast CancerCompletedNCT00331552Phase 1/2Results posted
• Using the Active Breathing Control Device to Reduce Radiation Side Effects to Critical Structures in Breast CancerCompletedNCT00328783Not applicableResults posted
• Partial Breast Irradiation (PBI) for Selected Patients With Early Breast CancerCompletedNCT00325598Phase 1/2Results posted
• Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast CancerCompletedNCT00325234Phase 2Results posted
• Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast CancerCompletedNCT00324259Phase 2Results posted
• Arthralgia During Anastrozole Therapy for Breast CancerCompletedNCT00323479Phase 4Results posted
• Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast CancerTerminatedNCT00323063Phase 2Results posted
• Phase I Combination w/ EpirubicinCompletedNCT00322374Phase 1Results posted
• Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal WomenCompletedNCT00322348Phase 2Results posted
• Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABCCompletedNCT00321048Not applicableResults posted
• Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast CancerCompletedNCT00320710Phase 3Results posted
• A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast CancerCompletedNCT00320541Phase 2Results posted
• GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast CancerCompletedNCT00320411Phase 2Results posted
• Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast CancerCompletedNCT00320385Phase 3Results posted
• Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast CancerCompletedNCT00319254Phase 2Results posted
• Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast CancerCompletedNCT00317720Phase 1/2Results posted
• Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer PatientsCompletedNCT00317603Phase 1Results posted
• Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast CancerCompletedNCT00316199Phase 2Results posted
• A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mgCompletedNCT00313170Phase 2Results posted
• Docetaxel in Breast CancerCompletedNCT00312208Phase 3Results posted
• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)Active, not recruitingNCT00310180Phase 3Results posted

← Breast Neoplasms overview